Cleared Traditional

K230286 - Assert-IQ™ Insertable Cardiac Monitor (FDA 510(k) Clearance)

May 2023
Decision
104d
Days
Class 2
Risk

K230286 is an FDA 510(k) clearance for the Assert-IQ™ Insertable Cardiac Monitor. This device is classified as a Recorder, Event, Implantable Cardiac, (without Arrhythmia Detection) (Class II - Special Controls, product code MXC).

Submitted by Abbott Medical (Sylmar, US). The FDA issued a Cleared decision on May 17, 2023, 104 days after receiving the submission on February 2, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2800.

Submission Details

510(k) Number K230286 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2023
Decision Date May 17, 2023
Days to Decision 104 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MXC — Recorder, Event, Implantable Cardiac, (without Arrhythmia Detection)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2800